Group 1 - The core point of the article is that 开拓药业-B (09939) is undergoing a share placement to raise funds for general operational purposes, with a significant discount on the share price [1] - On August 5, shareholders transferred shares worth HKD 47.9072 million from 中银国际证券 to 摩根士丹利香港证券, representing 5.12% of the total shares [1] - The company plans to place 20.673 million shares at a price of HKD 2.08 per share, which is an 18.75% discount compared to the previous closing price of HKD 2.56 [1] Group 2 - The estimated net proceeds from the share placement are approximately HKD 40.34 million, which will be used for general working capital and business operations [1] - Following the completion of the placement, the shareholding of the company's co-founder, chairman, executive director, and major shareholder 童友 will decrease from 11.19% to 10.69% [1]
开拓药业-B(09939)股东将股票由中银国际证券转入摩根士丹利香港证券 转仓市值4790.72万港元